Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/0690 stock hub

HKG/0690 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HKG/0690is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
549.4M
Hong Kong Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
HKG/0690
In the news

Latest news · HKG/0690

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11.7P50 18.9P75 41.4
Trailing P/E5.9
P25 10.7P50 17.9P75 38.5
ROE25.3
P25 -14.7P50 2P75 9.4
ROIC28.2
P25 -10.4P50 1.9P75 10.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HKG/0690 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
237
Groups with data
11
Currency
HKD
Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Cayman Islands
Country code
HK
Employees
543
Employees Change
56%
Employees Change Percent
11.5
Enterprise value
HKD 453.6M
Exchange
Hong Kong Stock Exchange
Financial currency
HKD
First seen
2026-05-10
Industry
Biotechnology
Isin
KYG9198H1406
Last refreshed
2026-05-10
Market cap
HKD 549.4M
Price
HKD 0.09
Price currency
HKD
Rev Per Employee
1,079,578.27x
Sector
Healthcare
Sic
2836
Symbol
hkg/0690
Website
https://www.uni-bioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
16.99%
EV Earnings
4.86x
EV/EBIT
4.65x
EV/EBITDA
3.94x
EV/FCF
12.41x
EV/Sales
0.77x
FCF yield
6.66%
P/B ratio
1.33x
P/E ratio
5.9x
P/S ratio
0.94x
PE Ratio10 Y
8.44x
PE Ratio3 Y
6.41x
PE Ratio5 Y
5.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
16.59%
EBITDA Margin
18.48%
FCF margin
6.24%
Gross margin
83.17%
Gross Profit
HKD 487.6M
Gross Profit Growth
0.62%
Gross Profit Growth Q
1.3%
Gross Profit Growth3 Y
4.72%
Gross Profit Growth5 Y
4.61%
Net Income
HKD 93.3M
Net Income Growth
12.75%
Net Income Growth Q
12.86%
Net Income Growth Quarters
2%
Net Income Growth Years
5%
Net Income Growth3 Y
-1.9%
Net Income Growth5 Y
8.08%
Pretax Margin
17.32%
Profit Margin
15.92%
Profit Per Employee
HKD 171,873
Profitable Years
4
ROA
11.08
Roa5y
9.66
ROCE
20.42
ROE
25.26
Roe5y
19.03
ROIC
28.16
Roic5y
32.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

25
MetricValue
Cagr10y
-4.69%
Cagr1y
23.78%
Cagr3y
20.84%
Cagr5y
-1.54%
Div CAGR10
1.23%
Div CAGR3
4.16%
Div CAGR5
2.47%
EPS Growth
15.73
EPS Growth Q
14.43
EPS Growth Quarters
2
EPS Growth Years
5
EPS Growth3 Y
-0.31
EPS Growth5 Y
9.42
FCF Growth
27.35%
FCF Growth3 Y
-16.5%
FCF Growth5 Y
-2.29%
OCF Growth
33.1%
OCF Growth Q
141.25%
OCF Growth3 Y
-10.18%
OCF Growth5 Y
5.03%
Revenue Growth
6.01x
Revenue Growth Q
-1.21x
Revenue Growth Years
5x
Revenue Growth3 Y
4.86x
Revenue Growth5 Y
3.45x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
HKD 1.07
Assets
HKD 579.8M
Cash
HKD 198.8M
Current Assets
HKD 334.3M
Current Liabilities
HKD 103.5M
Debt
HKD 103M
Debt EBITDA
HKD 0.9
Debt Equity
HKD 0.25
Debt FCF
HKD 2.82
Equity
HKD 413.2M
Interest Coverage
64.56
Liabilities
HKD 166.6M
Long Term Assets
HKD 245.5M
Long Term Liabilities
HKD 63M
Net Cash
HKD 95.8M
Net Cash By Market Cap
HKD 17.44
Net Cash Growth
48.68%
Net Debt EBITDA
HKD -0.88
Net Debt Equity
HKD -0.23
Net Debt FCF
HKD -2.62
Tangible Book Value
HKD 411.3M
Tangible Book Value Per Share
HKD 0.07
WACC
3.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.23
Inventory Turnover
2.79
Net Working Capital
HKD 75.5M
Quick ratio
2.79
Working Capital
HKD 230.8M
Working Capital Turnover
HKD 2.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
2.75%
Dividend Growth
13%
Dividend Growth Years
0%
Dividend per share
HKD 0
Dividend Years
2
Dividend Yield
3.4%
Ex Div Date
2026-05-28
Last Dividend
HKD 0
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-38.12%
1Y total return
23.77%
200-day SMA
0.12
3Y total return
76.48%
50-day SMA
0.1
50-day SMA vs 200-day SMA
50under200
5Y total return
-7.48%
All Time High
0.39
All Time High Change
-76.41%
All Time High Date
2014-01-30
All Time Low
0.04
All Time Low Change
135.9%
All Time Low Date
2022-12-05
ATR
0
Beta
-0.03
Beta1y
-0.51
Beta2y
-0.19
Ch YTD
-20
High
0.09
High52
0.17
High52 Date
2025-08-12
High52ch
-45.24%
Low
0.09
Low52
0.07
Low52 Date
2025-05-12
Low52ch
35.29%
Ma50ch
-12.13%
Price vs 200-day SMA
-25.57%
RSI
38.47
RSI Monthly
48.05
RSI Weekly
34.9
Sharpe ratio
0.63x
Sortino ratio
1.22
Total Return
6.15%
Tr YTD
-20
Tr1m
-8%
Tr1w
-3.16%
Tr3m
-17.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
HKD 97.2M
Operating Income Growth
-11.2
Operating Income Growth Q
-35.97
Operating Income Growth3 Y
-3.7
Operating Income Growth5 Y
5.84
Operating margin
16.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
3,142,984,245%
Net Borrowing
-16,138,000
Shares Insiders
47.36%
Shares Institutions
0.15%
Shares Out
5,971,228,147
Shares Qo Q
0%
Shares Yo Y
-2.75%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
HKD 35.6M
Average Volume
3,023,524.9x
Bv Per Share
0.07
CAPEX
HKD -52.2M
Ch10y
-40.26
Ch1m
-8
Ch1w
-3.16
Ch1y
19.48
Ch3m
-17.12
Ch3y
70.37
Ch5y
-10.68
Ch6m
-23.33
Change
-2.13%
Change From Open
-2.13
Close
0.09
Days Gap
0
Depreciation Amortization
11,091,000
Dollar Volume
241,040
Earnings Date
2026-03-27
EBIT
HKD 97.2M
EBITDA
HKD 108.3M
EPS
HKD 0.02
F Score
5
FCF
HKD 36.6M
FCF EV Yield
8.06x
FCF Per Share
HKD 0.01
Financing CF
-34,184,000
Fiscal Year End
December
Founded
2,001
Graham Number
0.15586
Graham Upside
69.41
Income Tax
HKD 8.2M
Investing CF
68,282,000
Is Primary Listing
1
Last Earnings Date
2026-03-27
Last Report Date
2025-12-31
Last Split Date
2009-08-31
Last Split Type
Reverse
Lynch Fair Value
HKD 0.13
Lynch Upside
37.05
Ma150
0.12
Ma150ch
-20.42%
Ma20
0.1
Ma20ch
-6.22%
Net CF
114,612,000
Open
0.09
P FCF Ratio
15.02
P OCF Ratio
6.19
Payment Date
2026-06-12
Position In Range
33.33
Ppne
178,075,000
Price Date
2026-05-08
Price EBITDA
HKD 5.07
Ptbv Ratio
1.34
Relative Volume
0.83x
Revenue
586,211,000x
SBC By Revenue
0.17x
Share Based Comp
1,011,000
Tax By Revenue
1.4x
Tax Rate
8.07%
Tr6m
-23.33%
Volume
2,620,000
Z Score
3.22
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

HKG/0690 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.4%
$0.00 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+2.5%
0 consecutive years of growth
Total shareholder yield
+6.2%
Next ex-dividend date: 2026-05-28
Performance

HKG/0690 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+23.8%
S&P 500 1Y: n/a
3Y total return
+76.5%
S&P 500 3Y: n/a
5Y total return
-7.5%
S&P 500 5Y: n/a
10Y total return
-38.1%
S&P 500 10Y: n/a
Ownership

Who owns HKG/0690?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.1%
Share of float held by funds and institutions
Insider ownership
+47.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-2.8%
Negative means the company is buying back shares.
Technical

HKG/0690 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
38.5
Neutral momentum band
Price vs 200-day MA
-25.6%
50/200-day relationship not available
Beta (5Y)
-0.03
Less volatile than the market
Sharpe ratio
0.63
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HKG/0690

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/0690 stock rating?

hkg/0690 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/0690 analysis?

The full report lives at /stocks/hkg/0690/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/0690?

The latest report frames hkg/0690 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/0690 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

hkg/0690 stock profile: metrics, valuation and analysis | دستیار هوشمند بازار سهام